Impedimed (ASX:IPD) Days Sales Outstanding

: 89.48 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

Impedimed's average Accounts Receivable for the six months ended in Dec. 2023 was A$2.31 Mil. Impedimed's Revenue for the six months ended in Dec. 2023 was A$4.70 Mil. Hence, Impedimed's Days Sales Outstanding for the six months ended in Dec. 2023 was 89.48.

The historical rank and industry rank for Impedimed's Days Sales Outstanding or its related term are showing as below:

ASX:IPD' s Days Sales Outstanding Range Over the Past 10 Years
Min: 40.24 Med: 65.22 Max: 102.19
Current: 92.27

During the past 13 years, Impedimed's highest Days Sales Outstanding was 102.19. The lowest was 40.24. And the median was 65.22.

ASX:IPD's Days Sales Outstanding is ranked worse than
75.71% of 807 companies
in the Medical Devices & Instruments industry
Industry Median: 63.7 vs ASX:IPD: 92.27

Impedimed's Days Sales Outstanding increased from Dec. 2022 (83.80) to Dec. 2023 (89.48).

Impedimed Days Sales Outstanding Historical Data

The historical data trend for Impedimed's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Impedimed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Sales Outstanding

Get a 7-Day Free Trial

100.33

55.03

62.95

67.49

69.97

Impedimed Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial															85.86	82.33	83.80	91.06	89.48

Competitive Comparison

For the Medical Devices subindustry, Impedimed's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Impedimed Days Sales Outstanding Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Impedimed's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Impedimed's Days Sales Outstanding falls into.

Impedimed Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Impedimed's Days Sales Outstanding for the fiscal year that ended in Jun. 2023 is calculated as

	Days Sales Outstanding (A: Jun. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2022 )	+	Accounts Receivable (A: Jun. 2023 ))	/	count )	/	Revenue (A: Jun. 2023 )	*	Days in Period
=	( (1.917	+	2.396)	/	2 )	/	11.249	*	365
=	2.1565					/	11.249	*	365
=	69.97

Impedimed's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Jun. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (2.396	+	2.215)	/	2 )	/	4.702	*	365 / 2
=	2.3055					/	4.702	*	365 / 2
=	89.48

Impedimed (ASX:IPD) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Impedimed Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Impedimed's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Impedimed (ASX:IPD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Impedimed Ltd (ASX:IPD) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

IPDQF:USA

Address

50 Parker Court, Unit 1, Pinkenba, QLD, AUS, 4008

Website

https://www.impedimed.com

Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates most of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The Company recognizes revenue from stand alone sale of Legacy Devices and Consumables, Sale of SOZO Device and Software Subscription Services.

Impedimed (ASX:IPD) Headlines

No Headlines